Skip to content

Model Dermatology helps trainees diagnose skin lesions in Seoul

In a Seoul trial of 576 patients with suspicious skin lesions, non-expert physicians using Model Dermatology diagnosed 53.9% correctly against 43.8% without it.

22
Benefit status
Reported
Evidence
Independently studied
Source published
Sources
3 publications

Benefits

Benefit

Diagnosed 53.9% correctly against 43.8% without it

Awaiting review

Outcome identifiers

Unresolved

Not reviewedUnresolved

Category

Improved Task Accuracy

Awaiting review

Status

Reported benefit

Awaiting review

Beneficiary groups

People. Organizations.

Awaiting review

Beneficiaries

Unresolved

Not reviewedUnresolved

Reach

Unresolved

Not reviewedUnresolved

Distribution and access

Unresolved

Not reviewedUnresolved

Duration

Unresolved

Not reviewedUnresolved

Expected?

Yes

Awaiting review

Costs and harms

Unresolved

Not reviewedUnresolved

AI system

System

Model Dermatology

Awaiting review

Model

This is an explicit unresolved assignment: the sources on record do not settle this question.

Not reviewedUnresolved

Release

Unresolved

Not reviewedUnresolved

Provider

Unresolved

Not reviewedUnresolved

Role

Unresolved

Not reviewedUnresolved

Configuration

Unresolved

Not reviewedUnresolved

Inputs and outputs

Unresolved

Not reviewedUnresolved

Autonomy

Unresolved

Not reviewedUnresolved

Workflow

Physicians saw the algorithm's suggestions in real time during the examination. Most of the gain came from physicians with little dermatology experience. Patients had Fitzpatrick skin types III or IV.

Awaiting review

Human oversight

Unresolved

Not reviewedUnresolved

Relation to AI

Patients were randomly assigned to examination with or without the algorithm, so the difference in accuracy is attributable to the algorithm.

Awaiting review

AI contribution

Patients were randomly assigned to examination with or without the algorithm, so the difference in accuracy is attributable to the algorithm.

Awaiting review

Measurement

Studies

Randomized. [2]

Fully reviewed: supporting details for Studies

Review date: 29 October 2026.

Sources: [2]

Study design

Randomized. [2]

Fully reviewed: supporting details for Study design

Review date: 29 October 2026.

Sources: [2]

Measurement

Top-1 diagnostic accuracy against final diagnosis. [2]

Fully reviewed: supporting details for Measurement

Review date: 29 October 2026.

Sources: [2]

Setting and sample

576 consecutive adults with suspicious skin lesions at a tertiary hospital in Seoul; eight non-expert physicians. [2]

Fully reviewed: supporting details for Setting and sample

Review date: 29 October 2026.

Sources: [2]

Measures

Diagnostic accuracy. [2]

Fully reviewed: supporting details for Measures

Review date: 29 October 2026.

Sources: [2]

Comparison

Unaided examination. [2]

Fully reviewed: supporting details for Comparison

Review date: 29 October 2026.

Sources: [2]

Results

53.9% vs 43.8% overall; 54.7% vs 30.7% for non-dermatology trainees. [2]

Fully reviewed: supporting details for Results

Review date: 29 October 2026.

Sources: [2]

Additional value from AI

10.1 percentage points overall. [2]

Fully reviewed: supporting details for Additional value from AI

Review date: 29 October 2026.

Sources: [2]

Limitations

Unmasked single-center design; no significant gain for dermatology residents; the developer is the first author. [2]

Fully reviewed: supporting details for Limitations

Review date: 29 October 2026.

Sources: [2]

Denominators

Real-time algorithm assistance in the AI group. [2]

Fully reviewed: supporting details for Denominators

Review date: 29 October 2026.

Sources: [2]

Materials for replication

Algorithm available at b2020.modelderm.com. [2]

Fully reviewed: supporting details for Materials for replication

Review date: 29 October 2026.

Sources: [2]

Money

Kind of value

The kind of monetary value is unclear.

Not reviewedUnresolved

Amount

The monetary value is not established.

Not reviewedUnresolved

Currency and prices

The currency and price basis are unclear.

Not reviewedUnresolved

Period and unit

The period and unit of the monetary estimate are unclear.

Not reviewedUnresolved

Realization

Whether the monetary value was realized is unclear.

Not reviewedUnresolved

Recipients and payers

The recipients and payers are unclear.

Not reviewedUnresolved

Gross or net

Whether the monetary figure includes costs is unclear.

Not reviewedUnresolved

Included costs

The costs included in the estimate are unclear.

Not reviewedUnresolved

Comparison

The financial comparison is not established.

Not reviewedUnresolved

Method

The method used to calculate monetary value is unclear.

Not reviewedUnresolved

Return and payback

The return on investment or payback period is not established.

Not reviewedUnresolved

People and places

Participants

Developer: Seung Seog Han (I Dermatology Clinic and IDerma, Inc.). Operator: Department of Dermatology, Asan Medical Center, Ulsan University College of Medicine.

Awaiting review

Jurisdictions

Benefit: Seoul, South Korea. Developer: South Korea. Operator: South Korea.

Awaiting review

Ownership and control

Unresolved

Not reviewedUnresolved

Dependencies

Unresolved

Not reviewedUnresolved

Cross-border connections

Unresolved

Not reviewedUnresolved

Geopolitical implications

The geopolitical implications are unclear.

Not reviewedUnresolved

Follow-up

Conditions for replication

Users must be non-experts for whom the suggestions add information. The algorithm must be right often enough; wrong top suggestions lowered trainee accuracy.

Awaiting review

Replication attempts

Unresolved

Not reviewedUnresolved

Later findings

Unresolved

Not reviewedUnresolved

Availability

Unresolved

Not reviewedUnresolved

Institutional decision

A relevant institutional decision has not been established.

Not reviewedUnresolved

Grounds

The grounds for an institutional decision are unclear.

Not reviewedUnresolved

Action and result

The result of an institutional decision is not established.

Not reviewedUnresolved

Success criterion

The criterion for a successful institutional decision is unclear.

Not reviewedUnresolved

Evidence

Source numbers

AIBD-0649-source-0001–0003

Awaiting review

Citations

Numbered references below.

Awaiting review

Language

Unresolved

Not reviewedUnresolved

Source relationships

Independent, Developer

Awaiting review

Original evidence

Unresolved

Not reviewedUnresolved

Access and versions

Unresolved

Not reviewedUnresolved

Supported findings

Unresolved

Not reviewedUnresolved

Evidence strength

Independently studied. Sources: one independent peer-reviewed study, the makers' peer-reviewed study and the makers' other source. The cited evidence includes no finding by a regulator or court. [1] [2] [3]

Fully reviewed: supporting details for Evidence strength

Review date: 29 October 2026.

Sources: [1] [2] [3]

Missing evidence

Unresolved

Not reviewedUnresolved

Grades

Assessed benefits

People. Organizations.

Awaiting review

Depth

People: 2. Organizations: 2.

Awaiting review

Reasons

People: Patients examined with the algorithm received a correct diagnosis in 53.9% of cases against 43.8% without it. Organizations: Non-dermatology trainees diagnosed 54.7% of lesions correctly with the algorithm against 30.7% without it.

Awaiting review

Observed or intended

Unresolved

Not reviewedUnresolved

Rubric

Unresolved

Not reviewedUnresolved

Assessor and date

Unresolved

Not reviewedUnresolved

Alternative assessments

Unresolved

Not reviewedUnresolved

Fill

Independently studied

Awaiting review

Entry details

Kind

The case describes an evaluation or a study. A single-center unmasked randomized controlled trial. [1]

Fully reviewed: supporting details for Kind

Review date: 29 October 2026.

Sources: [1]

Field

Healthcare.

Awaiting review

Purpose

Model Dermatology was built to suggest diagnoses for skin lesions from photographs. The higher diagnostic accuracy was that purpose.

Awaiting review

Dates

Source published: 18 February 2022. Updated: 29 October 2026.

Awaiting review

Stage

The system was used in a pilot. A single-center randomized trial in a tertiary hospital clinic. [1]

Fully reviewed: supporting details for Stage

Review date: 29 October 2026.

Sources: [1]

Version

SHA-256: dc1fdbc0f7ec…

Awaiting review: supporting details for Version

SHA-256 of the public case, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.

References

Other identifiers

Unresolved

Not reviewedUnresolved

Category mappings

Unresolved

Not reviewedUnresolved

Citable summary

Unresolved

Not reviewedUnresolved

Revisions

1 revision. Latest: 29 October 2026.

Awaiting review

Sources

  1. Peer-reviewed study Independent author

    Ang XL, Oh CC. The use of artificial intelligence for skin cancer detection in Asia: a systematic review. Diagnostics (Basel). 2025;15(7):939. doi:10.3390/diagnostics15070939

  2. Peer-reviewed study Developer

    Han SS, Kim YJ, Moon IJ, et al. Evaluation of Artificial Intelligence-Assisted Diagnosis of Skin Neoplasms: A Single-Center, Paralleled, Unmasked, Randomized Controlled Trial. J Invest Dermatol. 2022;142(9):2353-2362.e2. doi:10.1016/j.jid.2022.02.003

  3. Other Developer

    Model Dermatology web service (build 2020). b2020.modelderm.com.

Cite this case

BibTeX Download BibTeX

Version dc1fdbc0f7ec, archived in the edition of 29 October 2026

Benefit marks

Depth

The number and color show the depth of a benefit.

  1. Depth 1. A convenience, or time or money saved.
  2. Depth 2. A measurable improvement in a result or ability.
  3. Depth 3. A lasting change, an ability restored, or a risk removed.
  4. Depth 4. A serious harm averted or a serious condition resolved in time.
  5. Depth 5. A life or livelihood preserved, or a change documented across a population.

Beneficiary

  • Circle: a person
  • Square: an organization
  • Triangle: society

Evidence

  • Solid. A court or regulator found a benefit, or researchers independently studied it.

  • Hatched. Independent reporting.

  • Outline. Claimed by the parties. Only the people or organizations involved, or sources whose independence has not been assessed, support the benefit.

The fill changes with the evidence. The depth color stays the same.

How benefits are assessed